Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1999 Oct;81(4):329–332. doi: 10.1136/adc.81.4.329

Randomised trial of LHRH analogue treatment on final height in girls with onset of puberty aged 7.5-8.5 years

A Cassio 1, E Cacciari 1, A Balsamo 1, M Bal 1, D Tassinari 1
PMCID: PMC1718086  PMID: 10490438

Abstract

OBJECTIVE—To study the effectiveness of luteinising hormone releasing hormone (LHRH) analogues in improving final height in girls affected by early puberty.
PATIENTS—Forty six consecutive girls with onset of puberty aged 7.5-8.5 years randomly divided into two groups: one treated with 3.75 mg triptorelin intramuscularly every four weeks (group 1); and the other with no treatment (group 2).
RESULTS—Mean (SD) chronological age at onset of menarche was significantly higher in group 1 than in group 2 (11.9 (1.0) v 10.8 (0.7) years). However, mean (SD) height at menarche (152.7 (7.2) v 152.5(5.7) cm) and mean (SD) growth after menarche (4.9 (3.0) v 5.4(2.2) cm) were similar in both groups. The mean (SD) final height was similar in the two groups (group 1, 158.1 (6.2) cm; group 2, 158.6 (6.0) cm) and not significantly different from target height. Fourteen of 20 patients in group 1 and 12 of 18 patients in group 2 showed final height equal to or higher than target height. Final heights of girls with poor initial height prognosis were significantly lower than those of girls with good prognosis, but in patients with the same initial height prognosis, both groups showed final heights similar and not significantly different from their target heights.
CONCLUSIONS—LHRH analogue has no apparent effect on final height in subjects with onset of puberty between 7.5 and 8.5years.



Full Text

The Full Text of this article is available as a PDF (76.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antoniazzi F., Cisternino M., Nizzoli G., Bozzola M., Corrias A., De Luca F., De Sanctis C., Rigon F., Zamboni G., Bernasconi S. Final height in girls with central precocious puberty: comparison of two different luteinizing hormone-releasing hormone agonist treatments. Acta Paediatr. 1994 Oct;83(10):1052–1056. doi: 10.1111/j.1651-2227.1994.tb12984.x. [DOI] [PubMed] [Google Scholar]
  2. BAYLEY N., PINNEAU S. R. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr. 1952 Apr;40(4):423–441. doi: 10.1016/s0022-3476(52)80205-7. [DOI] [PubMed] [Google Scholar]
  3. Bassi F., Bartolini O., Neri A. S., Gheri R. G., Bucciantini S., Cheli D., Bruni V. Precocious puberty: auxological criteria discriminating different forms. J Endocrinol Invest. 1994 Nov;17(10):793–797. doi: 10.1007/BF03347778. [DOI] [PubMed] [Google Scholar]
  4. Boepple P. A., Mansfield M. J., Crawford J. D., Crigler J. F., Jr, Blizzard R. M., Crowley W. F., Jr Gonadotrophin-releasing hormone agonist treatment of central precocious puberty: an analysis of growth data in a developmental context. Acta Paediatr Scand Suppl. 1990;367:38–43. doi: 10.1111/j.1651-2227.1990.tb11630.x. [DOI] [PubMed] [Google Scholar]
  5. Brauner R., Adan L., Malandry F., Zantleifer D. Adult height in girls with idiopathic true precocious puberty. J Clin Endocrinol Metab. 1994 Aug;79(2):415–420. doi: 10.1210/jcem.79.2.8045957. [DOI] [PubMed] [Google Scholar]
  6. Brauner R., Malandry F., Rappaport R. Predictive factors for the effect of gonadotrophin releasing hormone analogue therapy on the height of girls with idiopathic central precocious puberty. Eur J Pediatr. 1992 Oct;151(10):728–730. doi: 10.1007/BF01959077. [DOI] [PubMed] [Google Scholar]
  7. Cacciari E., Cassio A., Balsamo A., Colli C., Cicognani A., Pirazzoli P., Tani G., Brondelli L., Mandini M., Bovicelli L. Long-term follow-up and final height in girls with central precocious puberty treated with luteinizing hormone-releasing hormone analogue nasal spray. Arch Pediatr Adolesc Med. 1994 Nov;148(11):1194–1199. doi: 10.1001/archpedi.1994.02170110080014. [DOI] [PubMed] [Google Scholar]
  8. Cacciari E., Corazza G. R., Salardi S., Pascucci M. G., Tacconi M., Cicognani A., Tassinari D., Biasco G., Volta U., Lazzari R. What will be the adult height of coeliac patients? Eur J Pediatr. 1991 Apr;150(6):407–409. doi: 10.1007/BF02093719. [DOI] [PubMed] [Google Scholar]
  9. Crowley W. F., Jr, Comite F., Vale W., Rivier J., Loriaux D. L., Cutler G. B., Jr Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab. 1981 Feb;52(2):370–372. doi: 10.1210/jcem-52-2-370. [DOI] [PubMed] [Google Scholar]
  10. Ghirri P., Bottone U., Gasperi M., Bernardini M., Coccoli L., Giovanelli R., Boldrini A. Final height in girls with slowly progressive untreated central precocious puberty. Gynecol Endocrinol. 1997 Oct;11(5):301–305. doi: 10.3109/09513599709152552. [DOI] [PubMed] [Google Scholar]
  11. Helm P., Grølund L. A halt in the secular trend towards earlier menarche in Denmark. Acta Obstet Gynecol Scand. 1998 Feb;77(2):198–200. [PubMed] [Google Scholar]
  12. Herman-Giddens M. E., Slora E. J., Wasserman R. C., Bourdony C. J., Bhapkar M. V., Koch G. G., Hasemeier C. M. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics. 1997 Apr;99(4):505–512. doi: 10.1542/peds.99.4.505. [DOI] [PubMed] [Google Scholar]
  13. Hümmelink R., Oostdijk W., Partsch C. J., Odink R. J., Drop S. L., Sippell W. G. Growth, bone maturation and height prediction after three years of therapy with the slow release GnRH-agonist Decapeptyl-Depot in children with central precocious puberty. Horm Metab Res. 1992 Mar;24(3):122–126. doi: 10.1055/s-2007-1003273. [DOI] [PubMed] [Google Scholar]
  14. Kauli R., Galatzer A., Kornreich L., Lazar L., Pertzelan A., Laron Z. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method. Horm Res. 1997;47(2):54–61. doi: 10.1159/000185432. [DOI] [PubMed] [Google Scholar]
  15. Kletter G. B., Kelch R. P. Clinical review 60: Effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty. J Clin Endocrinol Metab. 1994 Aug;79(2):331–334. doi: 10.1210/jcem.79.2.8045943. [DOI] [PubMed] [Google Scholar]
  16. Kreiter M., Burstein S., Rosenfield R. L., Moll G. W., Jr, Cara J. F., Yousefzadeh D. K., Cuttler L., Levitsky L. L. Preserving adult height potential in girls with idiopathic true precocious puberty. J Pediatr. 1990 Sep;117(3):364–370. doi: 10.1016/s0022-3476(05)81074-1. [DOI] [PubMed] [Google Scholar]
  17. Martí-Henneberg C., Vizmanos B. The duration of puberty in girls is related to the timing of its onset. J Pediatr. 1997 Oct;131(4):618–621. doi: 10.1016/s0022-3476(97)70073-8. [DOI] [PubMed] [Google Scholar]
  18. Murram D., Dewhurst J., Grant D. B. Precocious puberty: a follow up study. Arch Dis Child. 1984 Jan;59(1):77–78. doi: 10.1136/adc.59.1.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Oostdijk W., Rikken B., Schreuder S., Otten B., Odink R., Rouwé C., Jansen M., Gerver W. J., Waelkens J., Drop S. Final height in central precocious puberty after long term treatment with a slow release GnRH agonist. Arch Dis Child. 1996 Oct;75(4):292–297. doi: 10.1136/adc.75.4.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Paul D., Conte F. A., Grumbach M. M., Kaplan S. L. Long-term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years. J Clin Endocrinol Metab. 1995 Feb;80(2):546–551. doi: 10.1210/jcem.80.2.7852518. [DOI] [PubMed] [Google Scholar]
  21. Rosenfield R. L. Selection of children with precocious puberty for treatment with gonadotropin releasing hormone analogs. J Pediatr. 1994 Jun;124(6):989–991. doi: 10.1016/s0022-3476(05)83200-7. [DOI] [PubMed] [Google Scholar]
  22. Schoevaart C. E., Drop S. L., Otten B. J., Slijper F. M., Degenhart H. J. Growth analysis up to final height and psychosocial adjustment of treated and untreated patients with precocious puberty. Horm Res. 1990;34(5-6):197–203. doi: 10.1159/000181825. [DOI] [PubMed] [Google Scholar]
  23. Sigurjonsdottir T. J., Hayles A. B. Precocious puberty. A report of 96 cases. Am J Dis Child. 1968 Mar;115(3):309–321. doi: 10.1001/archpedi.1968.02100010311003. [DOI] [PubMed] [Google Scholar]
  24. Sorgo W., Kiraly E., Homoki J., Heinze E., Teller W. M., Bierich J. R., Moeller H., Ranke M. B., Butenandt O., Knorr D. The effects of cyproterone acetate on statural growth in children with precocious puberty. Acta Endocrinol (Copenh) 1987 May;115(1):44–56. doi: 10.1530/acta.0.1150044. [DOI] [PubMed] [Google Scholar]
  25. Tanner J. M., Goldstein H., Whitehouse R. H. Standards for children's height at ages 2-9 years allowing for heights of parents. Arch Dis Child. 1970 Dec;45(244):755–762. doi: 10.1136/adc.45.244.755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. de la Puente M. L., Canela J., Alvarez J., Salleras L., Vicens-Calvet E. Cross-sectional growth study of the child and adolescent population of Catalonia (Spain). Ann Hum Biol. 1997 Sep-Oct;24(5):435–452. doi: 10.1080/03014469700005202. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES